.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Deloitte
Boehringer Ingelheim
Teva
Express Scripts
Farmers Insurance
Chinese Patent Office
US Army
Cerilliant
McKesson

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018865

« Back to Dashboard

NDA 018865 describes BETAMETHASONE VALERATE, which is a drug marketed by Perrigo Uk Finco, Riconpharma Llc, Taro Pharm, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Taro, Sti Pharma Llc, Teva Pharms, and Actavis Mid Atlantic, and is included in eighteen NDAs. It is available from fifteen suppliers. Additional details are available on the BETAMETHASONE VALERATE profile page.

The generic ingredient in BETAMETHASONE VALERATE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.

Summary for 018865

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 018865

Medical Subject Heading (MeSH) Categories for 018865

Suppliers and Packaging for NDA: 018865

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 018865 NDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0033 0168-0033-15 15 g in 1 TUBE (0168-0033-15)
BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 018865 NDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0033 0168-0033-46 45 g in 1 TUBE (0168-0033-46)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrengthEQ 0.1% BASE
Approval Date:Aug 31, 1983TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
Accenture
Novartis
Colorcon
Cerilliant
QuintilesIMS
Fuji
Queensland Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot